Guest Blogs - Express Pharma

Patent pause: Link extensions to pendency

An emerging disruption in drug traceability for India and beyond

Powering India’s biologics future: Industry-academia partnerships as the engine of growth

Next phase of growth: The case for innovation-led pharma organisations in India

Phytopharmaceuticals in India: A case for perpetual ‘New Drug’-style regulation over ASU-style liberalisation and counterproductive genericisation.

Off label drug use and physician liability

India’s biopharma moment—If we get the ecosystem right

Clinical exclusivity for indigenous medicines can improve long-term affordability and access

The GLP-1 revolution

India’s opportunity to lead next generation injectable drug innovation